Research ArticleArticle
Antitumor Effects of Dehydroxymethylepoxyquinomicin, a Novel Nuclear Factor-κB Inhibitor, in Human Liver Cancer Cells Are Mediated through a Reactive Oxygen Species-Dependent Mechanism
Nadia Lampiasi, Antonina Azzolina, Natale D'Alessandro, Kazuo Umezawa, James A. McCubrey, Giuseppe Montalto and Melchiorre Cervello
Molecular Pharmacology August 2009, 76 (2) 290-300; DOI: https://doi.org/10.1124/mol.109.055418
Nadia Lampiasi
Antonina Azzolina
Natale D'Alessandro
Kazuo Umezawa
James A. McCubrey
Giuseppe Montalto
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Antitumor Effects of Dehydroxymethylepoxyquinomicin, a Novel Nuclear Factor-κB Inhibitor, in Human Liver Cancer Cells Are Mediated through a Reactive Oxygen Species-Dependent Mechanism
Nadia Lampiasi, Antonina Azzolina, Natale D'Alessandro, Kazuo Umezawa, James A. McCubrey, Giuseppe Montalto and Melchiorre Cervello
Molecular Pharmacology August 1, 2009, 76 (2) 290-300; DOI: https://doi.org/10.1124/mol.109.055418
Research ArticleArticle
Antitumor Effects of Dehydroxymethylepoxyquinomicin, a Novel Nuclear Factor-κB Inhibitor, in Human Liver Cancer Cells Are Mediated through a Reactive Oxygen Species-Dependent Mechanism
Nadia Lampiasi, Antonina Azzolina, Natale D'Alessandro, Kazuo Umezawa, James A. McCubrey, Giuseppe Montalto and Melchiorre Cervello
Molecular Pharmacology August 1, 2009, 76 (2) 290-300; DOI: https://doi.org/10.1124/mol.109.055418
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement